H. Sato

Effects of Empagliflozin on Progression of Chronic Kidney Disease: A Pre-Specified Secondary Analysis from the Empa-Kidney Trial

M. Seman, T. Miyatsuka, Y. Lee-Barkey, 2023, The lancet. Diabetes & endocrinology.

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial.

M. Seman, T. Miyatsuka, Y. Lee-Barkey, 2023, The lancet. Diabetes & endocrinology.

Analysis of Throughput for Multilayer Infrared Meanderline Waveplates References

G. A. Vawter, V. P. Yakunin, R. Marhefka, 2022 .